Max Fehlmann
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 9
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders 9
- Immunology top 5%
- T-cell and B-cell Immunology 10
- Cell Biology top 5%
-
- Pancreatic function and diabetes 24
-
- Drug Transport and Resistance Mechanisms 14
-
- Monoclonal and Polyclonal Antibodies Research 11
-
- Diabetes and associated disorders 8
-
- Metabolism, Diabetes, and Cancer 8
- Co-authors
- P FreychetClaude AusselBernard FerruàA Le CamD. A. S. G. MaryMichel SamsonE Van ObberghenSteen Gammeltoft
- Journals
- Biochemical Journal (9 papers)The Journal of Immunology (6 papers)Molecular and Cellular Endocrinology (5 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Max Fehlmann
88 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 96
- Biochemistry 248
- Clinical Biochemistry 154
- Immunology 463
- Cell Biology 351
- Endocrinology, Diabetes and Metabolism 335
Countries citing papers authored by Max Fehlmann
This map shows the geographic impact of Max Fehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Fehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Fehlmann more than expected).
Fields of papers citing papers by Max Fehlmann
This network shows the impact of papers produced by Max Fehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Fehlmann. The network helps show where Max Fehlmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Max Fehlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 9 | |
| 2 | 1991 | 2 | |
| 3 | 1991 | 2 | |
| 4 | 1991 | 7 | |
| 5 | 1989 | 23 | |
| 6 | 1989 | 4 | |
| 7 | 1989 | 3 | |
| 8 | 1989 | 5 | |
| 9 | 1989 | 2 | |
| 10 | 1989 | 17 | |
| 11 | 1988 | 47 | |
| 12 | 1988 | 5 | |
| 13 | 1988 | 6 | |
| 14 | 1988 | 29 | |
| 15 | 1988 | 42 | |
| 16 | 1987 | 6 | |
| 17 | 1980 | 1 | |
| 18 | 1979 | 28 | |
| 19 | 1979 | 142 | |
| 20 | 1975 | 4 |
About Max Fehlmann
Max Fehlmann is a scholar working on Biochemistry, Clinical Biochemistry, Physiology, Immunology and Molecular Biology, having authored 89 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (24 papers), Drug Transport and Resistance Mechanisms (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), T-cell and B-cell Immunology (10 papers), Amino Acid Enzymes and Metabolism (9 papers), Metabolism and Genetic Disorders (9 papers), Diabetes and associated disorders (8 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Biochemistry (248 citations), Clinical Biochemistry (154 citations), Immunology (463 citations), Cell Biology (351 citations) and Endocrinology, Diabetes and Metabolism (335 citations). Max Fehlmann has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include P Freychet, Claude Aussel, Bernard Ferruà, A Le Cam, D. A. S. G. Mary, Michel Samson, E Van Obberghen, Steen Gammeltoft, Emmanuel Van Obberghen and Jean‐François Peyron. Their work appears in journals such as Biochemical Journal, The Journal of Immunology, Molecular and Cellular Endocrinology, FEBS Letters and Biochimie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.